Cargando…
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
Oncolytic engineered herpes simplex viruses (HSVs) possess many biologic and functional attributes that support their use in clinical trials in children with solid tumors. Tumor cells, in an effort to escape regulatory mechanisms that would impair their growth and progression, have removed many mech...
Autores principales: | Friedman, Gregory K, Beierle, Elizabeth A, Gillespie, George Yancey, Markert, James M, Waters, Alicia M, Chen, Chun-Yu, Denton, Nicholas L, Haworth, Kellie B, Hutzen, Brian, Leddon, Jennifer L, Streby, Keri A, Wang, Pin-Yi, Cripe, Timothy P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589754/ https://www.ncbi.nlm.nih.gov/pubmed/26436134 http://dx.doi.org/10.1038/mto.2015.16 |
Ejemplares similares
-
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
por: Cripe, Timothy P, et al.
Publicado: (2015) -
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016) -
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013) -
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
por: Megison, Michael L., et al.
Publicado: (2014) -
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
por: Denton, Nicholas L., et al.
Publicado: (2018)